Herpes Clinical Trial Pipeline Highlights 2019 – Global Forecast to 2024 by Clinical Trial Stage, Drug Mechanism Class, Company – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global
Herpes Clinical Trial Pipeline Highlights – 2019” report has
been added to ResearchAndMarkets.com’s offering.

Herpes Pipeline Highlights – 2019, provides most up-to-date information
on key pipeline products in the global Herpes market. It covers emerging
therapies for Herpes in active clinical development stages including
early and late stage clinical trials. The pipeline data presented in
this report helps executives for tracking competition, identifying
partners, evaluating opportunities, formulating business development
strategies, and executing in-licensing and out-licensing deals.

Clinical Trial Stages:

The report provides Herpes pipeline products by clinical trial stages
including both early and late stage development – phase 3 clinical
trials, phase 2 clinical trials, phase 1 clinical trials, preclinical
research, and discovery stage.

Drug Mechanism Classes:

The report provides Herpes pipeline products by their dominant mechanism
of action/drug class. This helps executives categorize products based on
their drug class and also assess the strengths and weaknesses of
compounds.

Company:

The report provides Herpes pipeline products by the company.

Short-term Launch Highlights:

Find out which Herpes pipeline products will be launched in the US and
Ex-US till 2024.

Key Topics Covered:

1. Herpes Pipeline by Stages

2. Herpes Phase 3 Clinical Trial Insights

3. Herpes Phase 2 Clinical Trial Insights

4. Herpes Phase 1 Clinical Trial Insights

5. Herpes Preclinical Research Insights

6. Herpes Discovery Stage Insights

7. Appendix

8. Research Methodology

For more information about this report visit https://www.researchandmarkets.com/r/kjw78t

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For
E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Infectious
Diseases Drugs, Clinical
Trials, Sexual
and Reproductive Health Drugs